Thus, the above data suggests that miR-16 suppresses Cyclin D1 and Cyclin E1 expression in glioma, and miR-16 plays an important role in URGCP-mediated glioma growth in vitro and in vivo. The gene discussed is URGCP; the disease is central nervous system cancer.